It affects confidence, self-image, and quality of life in ways that people who haven't experienced it struggle to understand
The reduction by dutasteride of prostate cancer events (REDUCE) trial is another multicenter, randomized, international, placebocontrolled, double blind clinical trial initiated in 2003 to evaluate the ability of dutasteride to decrease the risk of biopsy detectable prostate cancer in men with moderately elevated PSA levels
For men already using Minoxidil on the face for beard growth, adding GHK-Cu is a logical enhancement
Many people ask whether they can pause treatment after reaching their goal or use these medications temporarily rather than long-term
Researchers found that patients who got the highest dose of the drug lost on average 15.6% of their body weight after 48 weeks, compared to the 2.2% body weight loss seen in patients who got a placebo
doi: 10.1111/j.1600-065X.2011.01015.x 46 BechtoldVSmolenKKBurnyWde AngelisSPDelandreSEssaghirAet al